RankAlpha logo
Back to Rankings

CMPS

COMPASS PathwaysF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
Current thesis
Positive late-stage readouts, constructive FDA interactions, and payer traction could re-rate COMPASS toward analyst upside within 12 months.
Posture
Defensive
Lead driver
Sentiment
What changed
3 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Binary clinical trial/readout failure
Momentum
81
Value
41
Sentiment
19
Setup hits (3d)
3 · Net Bullish
AI TargetsBase $8.17 · Bull $16.08 · Bear $5.48Analysis 2026-02-26; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-26 • Model: RankAlpha Sentiment AI
Investment thesis
As of 2026-09-10

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions

Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Bullish
Target $23.35
Why
Momentum81 · Δ7d -13.4
Value41 · Δ7d -0.0
Sentiment19 · Δ7d -9.0
So what
Weak posture (Net Bullish). Prioritize risk control and patience.

Confirming evidence

  • 3 setup hits (3d) with net bullish as of 2026-09-09.
  • Sentiment remains the lead driver in the composite, 7D delta -9.0.

Contradictions & invalidation

  • Binary clinical trial/readout failure
  • Dilution and financing needs
  • Trial failures, regulatory setbacks, or dilutive financings would compress multiples and push the share price materially lower.

Catalyst clock

2026-05-27

Analyst re-ratings / coverage updates

Lead driver: Sentiment · See AI snapshot
Momentum
81
9% active weight
Current posture
7d trendSoftening
Δ7d
-13.4
Δ21d
-8.8
Value
41
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
19
62% active weight
Current posture
7d trendSoftening
Δ7d
-9.0
Δ21d
-5.1
Why this grade

Composite grade F. Momentum 81.0 / Value 41.2 / Sentiment 19.4

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-02-26. Scenario method

B+
Bull case
20%
Probability
Target price
$16.08
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
Most likely
B
Base case
60%
Probability
Target price
$8.17
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
B-
Bear case
20%
Probability
Target price
$5.48
Analysis reference price unavailable
Analysis 2026-02-26 · RankAlpha Sentiment AI
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$1.86B
Beta
1.93
Shares Out
135.72M
P/E (TTM) · Derived
-4.4
P/S (TTM)
-
P/FCF (TTM) · Derived
-9.57
Rev YoY
-
EPS YoY
+352.1%
Gross Margin
-
Op Margin
-
Net Debt
-$114.95M
Current Ratio
1.30
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data